James A. Lico
President and Chief Executive Officer at Fortive
Thanks, Griffin, and good afternoon, everyone. We were very pleased with our second quarter results. As you can see on slide three, our performance once again highlighted the benefits of our strategy to provide differentiated connected workflow solutions for our customers, creating a portfolio with enhanced resilience and long-term earnings power. During the quarter, we capitalized on accelerating point-of-sale trends across a number of our larger businesses, continued growth from our software offerings and improving conditions across our key end markets. Against this backdrop, we delivered core revenue growth and adjusted operating profit margins that exceeded the high end of our guidance, driving exceptional earnings growth and free cash flow conversion. As we highlighted at our Investor Day on May 19, we are building on the foundation of our advantaged hardware positions and expanding our software capabilities to address our customer's critical workflow needs and accelerate their ongoing digital transformation. In the second quarter, our SaaS offerings delivered low double-digit growth, and we also drove significant improvement across our professional services offerings. We continue to see strong momentum at eMaint, including increasing demand from its expansion into the food and beverage, pharmaceutical and health care verticals. Gordian and Accruent both had strong quarters as they executed on opportunities provided by increasing demand from facility owner operators and improvements in access to customer sites. Both companies are well positioned to capitalize as customers focused on post-COVID return to work challenges and digital transformation priorities. Centers also performed very well in the quarter as access to hospital customers improved, executing on strong demand for its SaaS offerings among existing and new independent delivery network customers. Looking across the portfolio, we continue to be excited about our expanding offering of EHS workflow solutions, which are well positioned to meet the significant long-term sustainability requirements of our customers.
ISC and Intellect performed well, capitalizing on strong broad-based growth across end-markets and key geographies. At the same time, we are excited with the early progress at ehsAI where the company closed its largest deal to-date in its first joint marketing campaign with Intelex and generated strong growth in its sales pipeline. Throughout the second quarter, we continue to apply the Fortive Business System across the portfolio to drive innovation, growth and share gains. Deployment of our lean portfolio management toolset, which significantly accelerates the efficiency and impact of R&D investments, achieved a greater than 40% increase in our on-time program delivery. The application of FBS and digital analytics and search optimization generated 25% growth in digital traffic, from pre-pandemic levels across the portfolio. Meanwhile, the use of FBS growth tools has accelerated innovation at Fluke Health Solutions over the past 18 months and continues to drive excellent top line performance. We have created good early momentum in our partnership with Pioneer Square Labs including the recent spin-in of TeamSense, a provider of innovative workflow solutions to streamline communications with hourly workers. This marks the first business incubated at Pioneer Square Labs to be integrated into the Fortive portfolio. While still very early, we are pleased with the progress thus far at TeamSense and are excited to develop additional technologies that accelerate safety and productivity solutions for customers within our core markets. In early July, we announced the acquisition of service channel. The transaction brings a differentiated high-growth software business with an integrated service provider network and significant proprietary data assets to the portfolio, enhancing our ability to meet the evolving needs of facility owners around the world. Following the expected closing of the acquisition in Q3, we will have significant balance sheet capacity supported by our strong and resilient free cash flow generation.
As we highlighted at our Investor Day, we see substantial runway across our $40 billion served market for disciplined capital allocation to accelerate our strategy. Turning to a quick summary of the results in the quarter on slide four, we generated year-over-year total revenue growth of 26.7% as revenue strength exceeded the high end of our guidance. Adjusted operating margin was 22.2% while adjusted earnings per share was $0.66, representing a year-over-year increase of 53.5%.Given the outperformance for both top line and our adjusted operating margin we delivered $282 million of free cash flow, which represented 118% conversion of adjusted net income. On slide five, we take a closer look at the Intelligent Operating Solutions segment. iOS posted total revenue growth of 31.2% in the second quarter. This included mid-20% core growth in North America, low 30% core growth in Western Europe and low 20% core growth in China. Fluke's core revenue increased in the mid-30% range. Fluke also grew by mid-single digits on a sequential basis as we continue to see robust demand across its businesses, highlighted by growth at Fluke Industrial. Fluke Industrial generated share gains across a range of key channel partners and retail accounts as point-of-sale accelerated through the quarter. Fluke's broader ii900 Acoustic Imaging product line also continues to perform very well, as revenue approximately doubled in the quarter on strong growth across both Western Europe and North America. Fluke Networks also performed well, driven by the recent launch of its LinkIQ product line, which continues to exceed initial expectations tied to office reopenings and network modifications. In Fluke reliability, our efforts to accelerate performance of Pruftechnik are gaining traction as we took advantage of increasing demand for alignment and other services, while eMaint also delivered another strong quarter.
With the accelerated pace of orders at Fluke, we did see some backlog build due to supply chain responsiveness. Industrial Scientific increased by mid-teens, driven by strong execution in instruments and rental as demand from oil and gas markets rebounded and the business continued its expansion into new end markets. The company's iNet offering remained resilient, increasing by mid single-digits with net retention solidly above 100%. Intelex grew by high single-digits in Q2, reporting a record revenue quarter. Intelex continues to leverage FBS and has driven improvements in lead generation and funnel conversion. Also in the second quarter, Intelex disclosed multiple deals for its enhanced ESG platform to help customers launch, scale and optimize their sustainability programs and meet increasing demand for transparency on a growing set of critical non-financial reporting metrics. Accruent grew by mid single-digits in the second quarter with low double-digit growth in its SaaS business. Accruent generated strong sales and bookings for its Meridian solution for engineering document management and its maintenance connection, CMMS offerings. The business also capitalized on the strong demand for its EMS event, workspace and resource scheduling offerings as companies plan and execute their return-to-work strategies. The company continues to generate new customer logo wins and improving growth in recurring bookings. Importantly, Accruent also delivered improved performance in its professional service business, which generated mid single-digit growth as customer site access continue to improve. Gordian increased by mid-teens, driven by low 20% growth in the procurement business and high teens growth in estimating. Gordian generated a record month for procurement revenue in June with accelerating time lines for key projects across a number of large customers. This included increased project spend by the New York City Department of Education and School Construction Authority. Moving to Slide six. Precision Technologies segment posted a total revenue increase of 25.1% in the second quarter.
This included low 20% growth in North America, mid-20% growth in Western Europe and mid-teens growth in China. Tektronix increased by approximately 30%, with another quarter of strong demand across its product businesses, including accelerating point-of-sale trends in each of its major regions. Both mainstream and performance of oscilloscopes had a strong quarter with high demand for semiconductor, industrial manufacturing and communications applications. Tektronix service business again showed its stability and resilience increasing by low teens. Tektronix continues to benefit from the accelerated focus on driving innovation with Q2 new product introductions performing very well, including its family of automated test solutions for high-speed data transfer. In the second quarter, Tektronix held six regional innovation form events, which stimulated the adoption of its tech scope platform, resulting in accelerated funnel creation for the company's broader hardware and software offerings. Sensing Technologies increased by low teens in the second quarter with growth driven by continuation of the broad market recovery. Sensing performed very well in China with another quarter of mid-teens growth, driven by demand for factory automation solutions. Elsewhere, Anderson-Negele continues to make progress with its approval of its paperless process recorder IoT solution aimed at the dairy industry with broader commercial rollout expected in the second half of the year. Sensing also continues to drive market share gains elsewhere across its portfolio, particularly etc., led by its differentiated critical environment solution and strong demand across its HVAC customers. PacSci EMC grew in the low 20% range, with the business seeing some alleviation of the COVID-related shutdowns and approval delays that impacted shipments in previous quarters. PacSci EMC continues to see good growth in the commercial space market with the resumption of launches by OneWeb providing recurring revenue for smart controllers and initiators.
Also on July 20, we were excited to watch the company's mission-critical technology, ensure safe and reliable separation of Blue Origin's new Shepherd capsule from its booster during its maiden voyage. Moving to Advanced Healthcare Solutions on Slide seven. Total revenue increased 21.8%, including 11% core growth. This included high single-digit core growth in each of North America, Western Europe and China markets. ASP grew by high single digits in the second quarter, led by strong growth in Western Europe and China. ASP also realized improved growth in North America, highlighted by high single-digit growth in the US. Overall, ASP grew its consumable revenue high teens as the rate of elective procedures across most geographies continue to improve. While elective procedure volumes increased on a year-over-year basis, Q2 volumes came in a bit lower than expected at approximately 93% of pre-COVID levels, which was consistent with the Q1 exit rate. ASP also continued to expand its global installed base of terminal sterilization capital equipment, which grew at a 3.5% annualized rate in Q2. We expect this continued installed base expansion to provide an additional tailwind to consumable revenue as procedure volumes normalize going forward. Censis increased in the mid-20% range with mid-teens growth in its CensiTrac SaaS offering as well as strong growth in its professional services business. Many hospital customers are now allowing access to vendors which resulted in a significant increase in activity in the second quarter, particularly with integrated delivery networks. Fluke Health Solutions increased by low double digits even as it lapped a sizable COVID-related revenue tailwind in the prior year. FHS saw high-teens growth from its Optimize and OneQA software solutions, which benefited from accelerated growth investments over the last 18 months.
With that, I'll pass it over to Chuck, who will take you through some additional details on our margins, free cash flow and balance sheet.